Scale -

  • Revenue is 132 Rs Cr; Annual Growth is 331 %; Continuous Growth over 3 years; 5 Year CAGR is 254 %
  • Ebitda is 3.5 Rs Cr; Annual Growth is 2088 %; Continuous Growth over 3 years; in Bottom Quartile
  • PBT is 1.12 Rs Cr; Annual Growth is 2733 %; Continuous Decline over 3 years
  • PAT is 2.56 Rs Cr; Annual Growth is 3100 %; Continuous Growth over 3 years
  • Quarterly Revenue is 36.91 Rs Cr; in Bottom Quartile
  • Quarterly Ebitda is 1.3 Rs Cr; in Bottom Quartile

Profitability -

  • PBDIT Margin is 2.64 %; Annual Growth is 408 %; in Bottom Quartile
  • PAT Margin is 1.93 %; Annual Growth is 615 %; Continuous Growth over 3 years

Return -

  • ROCE is 6.7 %; Annual Growth is 1389 %; Continuous Growth over 3 years
  • ROA is 2.76 %; Annual Growth is 790 %; Continuous Growth over 3 years
  • ROE is 5.49 %; Annual Growth is 1044 %; Continuous Growth over 3 years
  • Asset Turnover is 221 %; Annual Growth is 24 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 112 %

Efficiency -

  • Inventory Turnover Ratio is 17.32; in Top Quartile; Annual Decline is -43 %
  • Operating cash flow is -22.39 Rs Cr; Annual Decline is -64 %; Continuous Decline over 3 years; in Bottom Quartile
  • Current Ratio is 2.14; 5 Year CAGR is -75 %
  • Quick Ratio is 1.79; 5 Year CAGR is -76 %

Solvancy -

  • Debt/Equity is 0.09; Annual Decline is -83 %
  • Long term Debt is 4.32 Rs Cr; Annual Decline is -54 %
  • Total Debt is 4.32 Rs Cr; Annual Decline is -54 %

Quality -

  • Operating cashflow/ebitda is -6.4 %; Annual Growth is 93 %; in Bottom Quartile
  • Operating cashflow/PAT is -8.75 %; Annual Growth is 95 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is -11 %; Annual Decline is -1022 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 1 %; Annual Decline is -64 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -63 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Novelix Pharmaceuticals passes all AGM resolutions with 99.97% support
Read More
  • Past/current